What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Print number 6320d
- Amend and recommit to health
- Print number 6320c
- Amend and recommit to health
- Print number 6320b
- Amend and recommit to health
- Print number 6320a
- Amend (t) and recommit to health
- Referred to health
- Referred to rules
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Provides that health maintenance organizations shall provide market access to diagnostic laboratories
In Assembly Committee · Health · Sponsor Felix Ortiz
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:S6320D
Title of bill
An act to amend the public health law and the insurance law, in relation to providing access to diagnostic laboratories by patients in health maintenance organizations
Purpose
Provide for market access to all diagnostic laboratories which meet the specific criteria in managed health care networks in order to provide for greater transparency in the managed care network environment. The bill will also provide for vacating exclusive control, possession or sale source agreements by managed care networks with a diagnostic laboratory, thereby increasing competition, lowering rates and, most importantly, increasing quality of care.
Summary of provisions
Section 4406 of the public health law is amended by adding a new subdivision 6. Section 4406-c of the public health law is amended by adding two new subdivisions 4-a and 4-b. Section 4804 of the insurance law is amended by adding a new subsection (g).
Justification
Healthcare providers, physicians, patients and including, but not limited to, Federally Qualified Health Centers (FQHC) have had to adjust to the diminishing choices of diagnostic laboratories. This reduction in access has likely been caused by market consolidations and exclusivity agreements that run contrary to the antitrust provisions of the Donnelly Act. Many of the exclusivity agreements by and between managed care network providers and a select few diagnostic laboratories has increased with the advent of not-for-profit managed care providers seeking public trading status. This is to the detriment, disadvantage and inconvenience of managed care networks such as these healthcare providers, physicians, patients and including, but not limited to, Federally Qualified Health Centers' (FQHC) and competitive market participation. This legislation shall ensure that managed care networks will not engage in any perceived o r actual restraint of trade, interference with free competition in business and commercial transactions, affect prices, restrict production, or otherwise control the market by exclusivity agreements.
Legislative history
New bill.
Fiscal implications
None.
Effective date
Shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.